EN
HI
Summary
As of 13 Nov, 2026, Astec Lifesciences stock price is ₹537. During the trading session, the stock has moved between an intraday low of ₹533.60 and an intraday high of ₹547.05. Over the last 52 weeks, Astec Lifesciences has traded between ₹509.60 and ₹941.75.
The stock has recorded a trading volume of 46,508 shares,. Its Average Traded Price (ATP) is ₹539.49, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 7 @ ₹537.00.
Astec Lifesciences has an upper circuit limit of ₹641.50 and a lower circuit limit of ₹427.70. The total value traded stands at ₹2.51 CR, and the delivery percentage for the day is 42.91%.
The stock is currently traded with a market lot size of 1. Astec Lifesciences also offers a dividend yield of 0%.
Astec Lifesciences Share Price Chart
Astec Lifesciences Share Key Metrics
Volume
46508.00
Market Cap
1196.59 CR
LTQ@LTP
7@537.00
ATP
539.49
Var Margin
27.91 %
Circuit Range
427.7-641.5
Delivery %
42.91 %
Value
2.51 CR
ASM/GSM
No
Market Lot
1
Astec Lifesciences Fundamentals
P/E Ratio
0
P/B Ratio
3.57
Div. Yield
0
Sector P/E
44.56
Sector P/B
1.92
Sec. Div. Yield
0.43
Astec Lifesciences Resistance and Support
Pivot 533.07
Resistance
First Resistance
556.54
Second Resistance
578.47
Third Resistance
601.94
Support
First Support
511.14
Second Support
487.67
Third Support
465.74
Astec Lifesciences Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Thu Nov 12 2026 | 535.55 | 537 | 0.45% | 547.05 | 533.6 |
| Wed Nov 11 2026 | 525.95 | 534.59 | 1.40% | 555 | 509.6 |
| Mon Nov 09 2026 | 563.09 | 527.2 | -7.07% | 577 | 518.79 |
Astec Lifesciences Corporate Actions
| Date | Agenda |
|---|---|
| 2026-10-26 | Quarterly Results |
| 2026-07-31 | Quarterly Results |
| 2026-04-27 | Audited Results |
| 2026-01-30 | Quarterly Results |
| 2025-10-29 | Quarterly Results |
| 2025-07-28 | Quarterly Results |
| 2025-06-30 | Right Issue of Equity Shares |
| 2025-06-24 | Others |
| 2025-04-23 | Audited Results |
| 2025-01-27 | Quarterly Results |
| 2024-10-25 | Quarterly Results |
Astec Lifesciences News
Astec Lifesciences Ltd - 533138 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Astec Lifesciences reported a Q2 FY27 net loss of Rs.37.4 crore, widening from a loss of Rs.24.4 crore last year. Total income fell 3% YoY to Rs.72.6 crore. The performance was impacted by lower volumes in enterprise products, reduced realizations, and a Rs.3 crore inventory write-down.
Oct 26 2026 19:07:47
Astec Lifesciences Ltd - 533138 - Board Meeting Outcome for Outcome Of Board Meeting
Astec LifeSciences announced its Q2 FY27 financial results with cons. revenue of ₹72.02 crores, down 2.3% YoY. The company's net loss widened to ₹37.40 crores compared to a loss of ₹24.42 crores in the corresponding quarter last year.
Oct 26 2026 16:53:37
Read More
Astec Lifesciences Management
| Name | Position |
|---|---|
| Tejashree Pradhan | Company Secretary & Compliance Officer |
| Nadir B Godrej | Chairman |
Astec Lifesciences Similar Stocks
Excel Industries Ltd.
984.05
30.70 (3.22%)
Southern Petrochemical Industries Corporation Ltd.
60.55
-0.91 (1.48%)
Indo Borax & Chemicals Ltd.
385.25
1.75 (0.46%)
TGV SRACC Ltd.
127.70
7.05 (5.84%)
Platinum Industries Ltd.
219.71
4.21 (1.95%)
Ultramarine & Pigments Ltd.
404.00
2.95 (0.74%)
The Andhra Sugars Ltd.
80.42
-1.68 (2.05%)
Punjab Chemicals & Crop Protection Ltd.
910.05
-1.95 (0.21%)
Tuticorin Alkali Chemicals and Fertilizers Ltd.
50.96
1.13 (2.27%)
Astec Lifesciences FAQs
The Buying Price of Astec Lifesciences share is 537 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Astec Lifesciences stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Astec Lifesciences, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Astec Lifesciences shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Astec Lifesciences shares is 3.57. Useful to assess the stock's value relative to its book value.
To assess Astec Lifesciences’s valuation compare Sector P/E, P/B which are 44.56 & 1.92 with sector averages, along with growth rates and financial metrics.
The Market Cap of Astec Lifesciences is 1196.59 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Astec Lifesciences share price is 941.75 & 509.60. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Astec Lifesciences belongs to the Chemicals sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in ASTEC
